Skip to content
Toggle Navigation
Home
Contact Us
About WDA
Make a Donation
Search for:
Become a Member
Make a Donation
Join our Email List
Toggle Navigation
Do I Have Wilson Disease?
Signs & Symptoms
Diagnosis
Family Genetics
Kayser-Fleischer Rings
Living With Wilson Disease
Copper Conscious Eating
Treatment
Centers of Excellence
Patient Registry Study
Monitoring Your Treatment
Pregnancy
Patient Assistance
New Diagnosis
Youth
Medical Professionals
Signs and Symptoms
Diagnosis
Treatment
Monitoring Treatment
Medication Compliance
Other Therapies
Resource Center
News
Webinars
Copper Connection Newsletter
Social Media
Patient Stories
Downloadable Publications
Scholarly Resources
Glossary
FAQ
Get Involved
Become a Member
Donate
Wilson Disease Awareness Day
Events
Participate
Volunteer
Support Group Meetings
Toggle Navigation
Do I Have Wilson Disease?
Signs & Symptoms
Diagnosis
Family Genetics
Kayser-Fleischer Rings
Living With Wilson Disease
Copper Conscious Eating
Treatment
Centers of Excellence
Patient Registry Study
Monitoring Your Treatment
Pregnancy
Patient Assistance
New Diagnosis
Youth
Medical Professionals
Signs and Symptoms
Diagnosis
Treatment
Monitoring Treatment
Medication Compliance
Other Therapies
Resource Center
News
Webinars
Copper Connection Newsletter
Social Media
Patient Stories
Downloadable Publications
Scholarly Resources
Glossary
FAQ
Get Involved
Become a Member
Donate
Wilson Disease Awareness Day
Events
Participate
Volunteer
Support Group Meetings
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
Home
»
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
Resource Center
News
Copper Connection Newsletter
Social Media
Patient Stories
Downloadable Publications
Scholarly Resources
Glossary
FAQ
News
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
Read more:
Press Release
By
Wilson Disease
Published On: October 25, 2024
Categories:
News and Notices
Share This Story, Choose Your Platform!
Page load link
Go to Top